Panacela Labs
New York · Founded 2011
About Panacela Labs
Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation. Panacela Labs is 54.6% owned by Cleveland BioLabs. Panacela Labs has residency in the Innovation Center "Skolkovo".
Company Facts
- Founded: 2011
- Legal name: PANACELA LABS INC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $39.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2015)
- Website: panacelalabs.com
- Phone: (716)849-6810
Social Profiles
Canonical: https://fsome.com/organization/panacela-labs-8253815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.